Alkem Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Keep track of all breaking news and updates on Alkem Laboratories Ltd. from all sources in a single place.

Load latest

Alkem Laboratories Ltd.

25 Feb 2025

5294.50

0.57%

Company Update

Alkem Laboratories Ltd - 539523 - Dislcosure letter under Regulation 11(5) of The Securities and Exchange …

BSE India

Samprada & Nanhamati Singh Family Trust has submitted a letter to Exchange on amendment to trust deed under Regulation 11(5) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

pdf

Alkem Laboratories Ltd.

22 Feb 2025

5294.50

0.57%

Alkem Labs promoters sell Rs 300-cr shares in block deal

Economic Times

Promoters of Alkem Laboratories sold shares worth 300.3 crore through Samprada & Nanhamati Singh Family Trust in a block deal on Friday, selling 641,000 shares at 4,680 each, representing 0.54% of the company's equity.

Alkem Laboratories Ltd. is trading above its 150 day SMA of 5215.9

SBI Mutual Fund buys shares of Alkem Laboratories for Rs 300 crore

Business Standard | 21 Feb 2025

Alkem Laboratories Ltd.

18 Feb 2025

5294.50

0.57%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meeting scheduled to be held 27th February, 2025.

pdf

Alkem Laboratories Ltd.

18 Feb 2025

5294.50

0.57%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you the Company has received an Order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

17 Feb 2025

5294.50

0.57%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meetings scheduled to be held on 24th February, 2025.

pdf

Alkem Laboratories Ltd.

14 Feb 2025

5294.50

0.57%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an Order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf